 Connection
Liron Caplan to Diphosphonates
This is a "connection" page, showing publications Liron Caplan has written about Diphosphonates.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.491 |
|
|
|
-
Caplan L, Pittman CB, Zeringue AL, Scherrer JF, Wehmeier KR, Cunningham FE, Eisen SA, McDonald JR. An observational study of musculoskeletal pain among patients receiving bisphosphonate therapy. Mayo Clin Proc. 2010 Apr; 85(4):341-8.
Score: 0.302
-
Pittman CB, Davis LA, Zeringue AL, Caplan L, Wehmeier KR, Scherrer JF, Xian H, Cunningham FE, McDonald JR, Arnold A, Eisen SA. Myocardial infarction risk among patients with fractures receiving bisphosphonates. Mayo Clin Proc. 2014 Jan; 89(1):43-51.
Score: 0.098
-
Richards JS, Cannon GW, Hayden CL, Amdur RL, Lazaro D, Mikuls TR, Reimold AM, Caplan L, Johnson DS, Schwab P, Cherascu BN, Kerr GS. Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012 Dec; 64(12):1864-70.
Score: 0.091
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|